SE449816B - Vattenfri spermiedodande komposition - Google Patents
Vattenfri spermiedodande kompositionInfo
- Publication number
- SE449816B SE449816B SE8103833A SE8103833A SE449816B SE 449816 B SE449816 B SE 449816B SE 8103833 A SE8103833 A SE 8103833A SE 8103833 A SE8103833 A SE 8103833A SE 449816 B SE449816 B SE 449816B
- Authority
- SE
- Sweden
- Prior art keywords
- spermicidal
- groups
- composition
- composition according
- absorbency
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 10
- 229920002307 Dextran Polymers 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 230000001150 spermicidal effect Effects 0.000 claims description 7
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 claims description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 3
- 125000000524 functional group Chemical group 0.000 claims description 3
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical group ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims description 2
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 125000004964 sulfoalkyl group Chemical group 0.000 claims description 2
- -1 sulfopropyl Chemical group 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims description 2
- ZSPDDMXDEWGOCE-UHFFFAOYSA-N triethyl(2-hydroxypropyl)azanium Chemical group CC[N+](CC)(CC)CC(C)O ZSPDDMXDEWGOCE-UHFFFAOYSA-N 0.000 claims description 2
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims 1
- 239000007788 liquid Substances 0.000 description 10
- 239000003981 vehicle Substances 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 239000010695 polyglycol Substances 0.000 description 3
- 229920000151 polyglycol Polymers 0.000 description 3
- FBWNMEQMRUMQSO-UHFFFAOYSA-N tergitol NP-9 Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 FBWNMEQMRUMQSO-UHFFFAOYSA-N 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 239000000969 carrier Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WPRAXAOJIODQJR-UHFFFAOYSA-N 1-(3,4-dimethylphenyl)ethanone Chemical compound CC(=O)C1=CC=C(C)C(C)=C1 WPRAXAOJIODQJR-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940033134 talc Drugs 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/14—Topical contraceptives and spermacides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22910/80A IT1131833B (it) | 1980-06-20 | 1980-06-20 | Eccipienti per sostanze spermicide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8103833L SE8103833L (sv) | 1981-12-21 |
| SE449816B true SE449816B (sv) | 1987-05-25 |
Family
ID=11201796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8103833A SE449816B (sv) | 1980-06-20 | 1981-06-18 | Vattenfri spermiedodande komposition |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4371518A (de) |
| JP (1) | JPS5731607A (de) |
| AT (1) | AT390882B (de) |
| AU (1) | AU546430B2 (de) |
| BE (1) | BE889146A (de) |
| CA (1) | CA1148861A (de) |
| CH (1) | CH650156A5 (de) |
| DE (1) | DE3123823C2 (de) |
| DK (1) | DK158034C (de) |
| FR (1) | FR2484838A1 (de) |
| GB (1) | GB2078110B (de) |
| IT (1) | IT1131833B (de) |
| NL (1) | NL187893C (de) |
| PH (1) | PH16868A (de) |
| SE (1) | SE449816B (de) |
| ZA (1) | ZA813735B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403359D0 (en) * | 1984-02-08 | 1984-03-14 | Erba Farmitalia | Pharmaceutical compositions |
| US5208257A (en) * | 1986-04-21 | 1993-05-04 | Kabara Jon J | Topical antimicrobial pharmaceutical compositions and methods |
| CA1331559C (en) | 1986-04-21 | 1994-08-23 | Jon Joseph Kabara | Antimicrobial preservative compositions and methods |
| IT1213323B (it) * | 1986-08-07 | 1989-12-20 | Crinos Industria Farmaco | Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida |
| DK89592D0 (da) * | 1992-07-07 | 1992-07-07 | Helle Broendsted | Laegemiddelafgivelsesindretning samt fremgangsmaade til fremstilling deraf |
| ZA947572B (en) * | 1993-09-29 | 1995-09-28 | Hampton Roads Medical College | Contraceptive compositions |
| JPH09503763A (ja) * | 1993-09-29 | 1997-04-15 | ザ・メディカル・カレッジ・オブ・ハンプトン・ローズ・オン・ビハーフ・オブ・ザ・コンラッド・プログラム | 避妊用組成物 |
| WO2004075854A2 (en) * | 2003-02-26 | 2004-09-10 | Program For Appropriate Technology In Health | Microbicidal compositions and method of use |
| WO2004105662A1 (en) * | 2003-05-23 | 2004-12-09 | Program For Appropriate Technology In Health | Microbicidal compositions and methods of use |
| JP2007518394A (ja) * | 2003-08-14 | 2007-07-12 | ザ バイオ バランス コーポレイション | 細菌菌株、該細菌菌株を含む組成物、およびそのプロバイオティクス使用 |
| UA93354C2 (ru) * | 2004-07-09 | 2011-02-10 | Гилиад Сайенсиз, Инк. | Местный противовирусный препарат |
| AP2012006292A0 (en) | 2009-12-01 | 2012-06-30 | Seprox Biotech Sl | Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection. |
| EP2546358A1 (de) | 2011-07-15 | 2013-01-16 | Laboratorios Del. Dr. Esteve, S.A. | Verfahren und Reagenzien zur effizienten Steuerung des HIV-Fortschritts |
| EP2606897A1 (de) | 2011-12-22 | 2013-06-26 | Laboratorios Del. Dr. Esteve, S.A. | Verfahren und Zusammensetzungen für die Behandlung von Krankheiten, die von eingehüllten Viren verursacht werden |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL255047A (de) * | 1959-08-21 | |||
| JPS4113117Y1 (de) * | 1964-07-20 | 1966-06-21 | ||
| JPS4113118Y1 (de) * | 1964-09-26 | 1966-06-21 | ||
| JPS5025744U (de) * | 1973-07-12 | 1975-03-25 | ||
| US4242359A (en) * | 1977-04-01 | 1980-12-30 | Cornell Research Foundation, Inc. | Spermicidal agents |
| JPS5592312A (en) * | 1978-12-29 | 1980-07-12 | Yamanouchi Pharmaceut Co Ltd | Suppository containing bronchodilating compound |
| US4187286A (en) * | 1979-01-02 | 1980-02-05 | G&W Laboratories, Inc. | Contraceptive suppository |
| SE431937B (sv) * | 1979-01-29 | 1984-03-12 | Perstorp Ab | Salicylazosulfapyridinhaltigt medicinskt preparat |
| SE431821B (sv) * | 1979-01-29 | 1984-03-05 | Perstorp Ab | Lagringsstabilt, prostaglandininnehallande medicinskt preparat |
-
1980
- 1980-06-20 IT IT22910/80A patent/IT1131833B/it active
-
1981
- 1981-05-26 US US06/267,393 patent/US4371518A/en not_active Expired - Lifetime
- 1981-05-26 GB GB8115940A patent/GB2078110B/en not_active Expired
- 1981-06-01 CA CA000378735A patent/CA1148861A/en not_active Expired
- 1981-06-02 NL NLAANVRAGE8102675,A patent/NL187893C/xx not_active IP Right Cessation
- 1981-06-04 ZA ZA00813735A patent/ZA813735B/xx unknown
- 1981-06-09 BE BE0/205042A patent/BE889146A/fr not_active IP Right Cessation
- 1981-06-11 AU AU71651/81A patent/AU546430B2/en not_active Ceased
- 1981-06-16 FR FR8111810A patent/FR2484838A1/fr active Granted
- 1981-06-16 DE DE3123823A patent/DE3123823C2/de not_active Expired
- 1981-06-16 CH CH3969/81A patent/CH650156A5/it not_active IP Right Cessation
- 1981-06-16 JP JP9290881A patent/JPS5731607A/ja active Granted
- 1981-06-18 SE SE8103833A patent/SE449816B/sv not_active IP Right Cessation
- 1981-06-19 AT AT0272181A patent/AT390882B/de active
- 1981-06-19 PH PH25786A patent/PH16868A/en unknown
- 1981-06-19 DK DK270181A patent/DK158034C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IT8022910A0 (it) | 1980-06-20 |
| BE889146A (fr) | 1981-10-01 |
| GB2078110A (en) | 1982-01-06 |
| CH650156A5 (it) | 1985-07-15 |
| DK158034C (da) | 1990-08-13 |
| PH16868A (en) | 1984-03-26 |
| FR2484838A1 (fr) | 1981-12-24 |
| AU7165181A (en) | 1981-12-24 |
| NL187893B (nl) | 1991-09-16 |
| ZA813735B (en) | 1982-06-30 |
| NL187893C (nl) | 1992-02-17 |
| DE3123823C2 (de) | 1987-01-02 |
| AU546430B2 (en) | 1985-08-29 |
| DE3123823A1 (de) | 1982-04-22 |
| SE8103833L (sv) | 1981-12-21 |
| CA1148861A (en) | 1983-06-28 |
| JPH0371403B2 (de) | 1991-11-13 |
| GB2078110B (en) | 1984-05-16 |
| JPS5731607A (en) | 1982-02-20 |
| US4371518A (en) | 1983-02-01 |
| IT1131833B (it) | 1986-06-25 |
| NL8102675A (nl) | 1982-01-18 |
| AT390882B (de) | 1990-07-10 |
| ATA272181A (de) | 1990-01-15 |
| DK158034B (da) | 1990-03-19 |
| FR2484838B1 (de) | 1985-05-03 |
| DK270181A (da) | 1981-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5545401A (en) | Antiviral, spermicidal vaginal gel and foam containing low molecular weight povidone-iodine | |
| Maguire et al. | Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization | |
| US4371518A (en) | Carriers for spermicidal substances | |
| Taylor | Histochemical studies of nephrotoxicity with sublethal doses of mercury in rats | |
| DE2755505A1 (de) | Abgabemittel fuer biologisch aktive stoffe | |
| EP1996209B1 (de) | Kontrazeptive zusammensetzung | |
| SE431821B (sv) | Lagringsstabilt, prostaglandininnehallande medicinskt preparat | |
| Moyer et al. | Reactions of human endometrium to the intrauterine device: I. Correlation of the endometrial histology with the bacterial environment of the uterus following short-term insertion of the IUD | |
| Lolley et al. | ALTERATIONS IN CYCLIC AMP METABOLISM ASSOCIATED WITH PHOTORECEPTOR CELL DEGENERATION IN THE C3H MOUSE 1 | |
| CA1216237A (en) | Contraceptive composition | |
| Gagné et al. | Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9 | |
| Andersen et al. | A comparison of single‐dose oral fluconazole with 3‐day intravaginal clotrimazole in the treatment of vaginal candidiasis: report of an international multicentre trial | |
| JPS6379816A (ja) | 局所用法のための組成物 | |
| Hottendorf et al. | Nonparallel nephrotoxicity dose-response curves of aminoglycosides | |
| CN105555281A (zh) | 用于递送抗菌组合物的独特结合的阴道环 | |
| Kuhn et al. | Nephrotoxicity of cis-Diamminedichloroplatinum (II) as Measured by Urinary ẞ-Glucuronidase 1, 2, 3 | |
| Bernstein | Physiological aspects of vaginal contraception a review | |
| Harvey et al. | Spermicidal activity of surface-active agents | |
| Cummings | Effect of 5-azacytidine administration during very early pregnancy | |
| Boyd et al. | Absorption of two trimethoprim/sulphonamide combinations from the uterus of pony mares | |
| Levine et al. | Mutagenic potential of cis-dichlorodiammine platinum II in rodents | |
| Hurd et al. | Association of interstitial nephritis with tubule cell injury and proliferation in NZB/NZW mice | |
| CA2173101A1 (en) | Contraceptive compositions | |
| Tewari | Studies on experimental Fasciola hepatica infections in the guinea-pig | |
| Chandranondnaiwinit et al. | Modification of polyethylene glycol ointment USP XVI |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8103833-3 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8103833-3 Format of ref document f/p: F |